{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:19:50Z","timestamp":1793841590430,"version":"4.6.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12876-016-0439-y","type":"journal-article","created":{"date-parts":[[2016,3,10]],"date-time":"2016-03-10T16:38:20Z","timestamp":1457627900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Reversible normalisation of serum TSH levels in patients with autoimmune atrophic gastritis who received L-T4 in tablet form after switching to an oral liquid formulation: a case series"],"prefix":"10.1186","volume":"16","author":[{"given":"Poupak","family":"Fallahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Martina","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Ruffilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessando","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,24]]},"reference":[{"key":"439_CR1","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.beem.2009.06.006","volume":"23","author":"L Liwanpo","year":"2009","unstructured":"Liwanpo L, Hershman JM. Conditions and drugs interfering with thyroxine absorption. Best Pract Res Clin Endocrinol Metab. 2009;23:781\u201392.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"439_CR2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1089\/thy.2007.0381","volume":"18","author":"S Ananthakrishnan","year":"2008","unstructured":"Ananthakrishnan S, Braverman LE, Levin RM, Magnani B, Pearce EN. The effect of famotidine, esomeprazole, and ezetimibe on levothyroxine absorption. Thyroid. 2008;18:493\u20138.","journal-title":"Thyroid"},{"key":"439_CR3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1523-5378.1997.tb00060.x","volume":"2","author":"B Annibale","year":"1997","unstructured":"Annibale B, Marignani M, Azzoni C, D\u2019Ambra G, Caruana P, D\u2019Adda T, et al. Atrophic body gastritis: distinct features associated with helicobacter pylori infection. Helicobacter. 1997;2:57\u201364.","journal-title":"Helicobacter"},{"key":"439_CR4","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1001\/archinte.159.15.1726","volume":"159","author":"M Centanni","year":"1999","unstructured":"Centanni M, Marignani M, Gargano L, Corleto VD, Casini A, Delle Fave G, et al. Atrophic body gastritis in patients with autoimmune thyroid disease: an underdiagnosed association. Arch Intern Med. 1999;159:1726\u201330.","journal-title":"Arch Intern Med"},{"key":"439_CR5","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa043903","volume":"354","author":"M Centanni","year":"2006","unstructured":"Centanni M, Gargano L, Canettieri G, Viceconti N, Franchi A, Delle Fave G, et al. Thyroxine in goiter, helicobacter pylori infection, and chronic gastritis. N Engl J Med. 2006;354:1787\u201395.","journal-title":"N Engl J Med"},{"key":"439_CR6","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1517\/17425247.2014.918101","volume":"11","author":"R Vita","year":"2014","unstructured":"Vita R, Fallahi P, Antonelli A, Benvenga S. The administration of L-thyroxine as soft gel capsule or liquid solution. Expert Opin Drug Deliv. 2014;11:1103\u201311.","journal-title":"Expert Opin Drug Deliv"},{"key":"439_CR7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","volume":"14","author":"A Antonelli","year":"2015","unstructured":"Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Autoimmune thyroid disorders. Autoimmun Rev. 2015;14:174\u201380.","journal-title":"Autoimmun Rev"},{"key":"439_CR8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1210\/jc.2007-1544","volume":"93","author":"S Checchi","year":"2008","unstructured":"Checchi S, Montanaro A, Pasqui L, Ciuoli C, De Palo V, Chiappetta MC, et al. L-thyroxine requirement in patients with autoimmune hypothyroidism and parietal cell antibodies. J Clin Endocrinol Metab. 2008;93:465\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"439_CR9","doi-asserted-by":"crossref","unstructured":"Fallahi P, Ferrari SM, Antonelli A. Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study. Endocrine. 2015 Dec 31. [Epub ahead of print]","DOI":"10.1007\/s12020-015-0836-y"},{"key":"439_CR10","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s11695-013-1015-y","volume":"23","author":"I Pirola","year":"2013","unstructured":"Pirola I, Formenti AM, Gandossi E, Mittempergher F, Casella C, Agosti B, et al. Oral liquid L-thyroxine (L-t4) may be better absorbed compared to L-T4 tablets following bariatric surgery. Obes Surg. 2013;23:1493\u20136.","journal-title":"Obes Surg"},{"key":"439_CR11","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJM198703263161302","volume":"316","author":"LH Fish","year":"1987","unstructured":"Fish LH, Schwartz HL, Cavanaugh J, Steffes MW, Bantle JP, Oppenheimer JH. Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans. N Engl J Med. 1987;316:764\u201370.","journal-title":"N Engl J Med"},{"key":"439_CR12","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/00007611-200194080-00017","volume":"94","author":"MS Eledrisi","year":"2001","unstructured":"Eledrisi MS, Szymajda A, Alshanti M, Urban RJ. Noncompliance with medical treatment: pseudomalabsorption of levothyroxine. South Med J. 2001;94:833\u20136.","journal-title":"South Med J"},{"key":"439_CR13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejpb.2008.10.008","volume":"72","author":"D Pabla","year":"2009","unstructured":"Pabla D, Akhlaghi F, Zia H. A comparative pH-dissolution profile study of selected commercial levothyroxine products using inductively coupled plasma mass spectrometry. Eur J Pharm Biopharm. 2009;72:105\u201310.","journal-title":"Eur J Pharm Biopharm"},{"key":"439_CR14","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/00045391-199510000-00014","volume":"2","author":"SI Sherman","year":"1995","unstructured":"Sherman SI, Malecha SE. Absorption and malabsorption of levothyroxine sodium. Am J Ther. 1995;2:814\u20138.","journal-title":"Am J Ther"},{"key":"439_CR15","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-119-6-199309150-00009","volume":"119","author":"SJ Mandel","year":"1993","unstructured":"Mandel SJ, Brent GA, Larsen PR. Levothyroxine therapy in patients with thyroid disease. Ann Intern Med. 1993;119:492\u2013502.","journal-title":"Ann Intern Med"},{"key":"439_CR16","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1053\/j.gastro.2008.05.021","volume":"134","author":"ML Schubert","year":"2008","unstructured":"Schubert ML, Peura DA. Control of gastric acid secretion in health and disease. Gastroenterology. 2008;134:1842\u201360.","journal-title":"Gastroenterology"},{"key":"439_CR17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4158\/EP.13.4.345","volume":"13","author":"I Sachmechi","year":"2007","unstructured":"Sachmechi I, Reich DM, Aninyei M, Wibowo F, Gupta G, Kim PJ. Effect of proton pump inhibitors on serum thyroid-stimulating hormone level in euthyroid patients treated with levothyroxine for hypothyroidism. Endocr Pract. 2007;13:345\u20139.","journal-title":"Endocr Pract"},{"key":"439_CR18","first-page":"16","volume":"48","author":"PB Ant\u00fanez","year":"2011","unstructured":"Ant\u00fanez PB, Licht SD. Vitamin C improves the apparent absorption of levothyroxine in a subset of patients receiving this hormone for primary hypothyroidism. Rev Argent Endocrinol Metab. 2011;48:16\u201324.","journal-title":"Rev Argent Endocrinol Metab"},{"key":"439_CR19","doi-asserted-by":"crossref","first-page":"E1031","DOI":"10.1210\/jc.2013-4360","volume":"99","author":"W Jubiz","year":"2014","unstructured":"Jubiz W, Ramirez M. Effect of vitamin C on the absorption of levothyroxine in patients with hypothyroidism and gastritis. J Clin Endocrinol Metab. 2014;99:E1031\u20134.","journal-title":"J Clin Endocrinol Metab"},{"key":"439_CR20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1467-789X.2009.00614.x","volume":"11","author":"R Padwal","year":"2010","unstructured":"Padwal R, Brocks D, Sharma AM. A systematic review of drug absorption following bariatric surgery and its theoretical implications. Obes Rev. 2010;11:41\u201350.","journal-title":"Obes Rev"},{"key":"439_CR21","unstructured":"Saraceno G, Vita R, Trimarchi F, Benvenga S. A liquid formulation of L-thyroxine (L-T4) solves problems of incomplete normalization\/suppression of serum TSH caused by proton pump inhibitors (PPI) on conventional tablet formulations of L-T4. Presented at European Society of Endocrinology ICE\/ECE, Florence, IT, 2012, p. 1626 (Abstract 29)"},{"key":"439_CR22","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.2165\/00003088-200443140-00006","volume":"43","author":"I Walter-Sack","year":"2004","unstructured":"Walter-Sack I, Clanget C, Ding R, Goeggelmann C, Hinke V, Lang M, et al. Assessment of levothyroxine sodium bioavailability: recommendations for an improved methodology based on the pooled analysis of eight identically designed trials with 396 drug exposures. Clin Pharmacokinet. 2004;43:1037\u201353.","journal-title":"Clin Pharmacokinet"},{"key":"439_CR23","first-page":"680","volume":"54","author":"R Koytchev","year":"2004","unstructured":"Koytchev R, Lauschner R. Bioequivalence study of levothyroxine tablets compared to reference tablets and an oral solution. Arzneimittelforschung. 2004;54:680\u20134.","journal-title":"Arzneimittelforschung"},{"key":"439_CR24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF03191122","volume":"31","author":"N Yannovits","year":"2006","unstructured":"Yannovits N, Zintzaras E, Pouli A, Koukoulis G, Lyberi S, Savari E, et al. A bioequivalence study of levothyroxine tablets versus an oral levothyroxine solution in healthy volunteers. Eur J Drug Metab Pharmacokinet. 2006;31:73\u20138.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"439_CR25","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1055\/s-0032-1329951","volume":"62","author":"CS Yue","year":"2012","unstructured":"Yue CS, Scarsi C, Ducharme MP. Pharmacokinetics and potential advantages of a new oral solution of levothyroxine vs. Other available dosage forms. Arzneimittelforschung. 2012;62:631\u20136.","journal-title":"Arzneimittelforschung"},{"key":"439_CR26","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/00003088-200241090-00003","volume":"41","author":"H Zhang","year":"2002","unstructured":"Zhang H, Zhang J, Streisand JB. Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications. Clin Pharmacokinet. 2002;41:661\u201380.","journal-title":"Clin Pharmacokinet"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-016-0439-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T08:04:10Z","timestamp":1498291450000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-230X\/16\/22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,24]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["439"],"URL":"https:\/\/doi.org\/10.1186\/s12876-016-0439-y","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,24]]},"article-number":"22"}}